These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19791801)

  • 1. Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors.
    Renard JF; Arslan D; Garbacki N; Pirotte B; de Leval X
    J Med Chem; 2009 Oct; 52(19):5864-71. PubMed ID: 19791801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors.
    Julémont F; de Leval X; Michaux C; Renard JF; Winum JY; Montero JL; Damas J; Dogné JM; Pirotte B
    J Med Chem; 2004 Dec; 47(27):6749-59. PubMed ID: 15615524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
    Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
    Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
    Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
    Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism.
    Renard JF; Lecomte F; Hubert P; de Leval X; Pirotte B
    Eur J Med Chem; 2014 Mar; 74():12-22. PubMed ID: 24440378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
    Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors.
    Chandna N; Kumar S; Kaushik P; Kaushik D; Roy SK; Gupta GK; Jachak SM; Kapoor JK; Sharma PK
    Bioorg Med Chem; 2013 Aug; 21(15):4581-90. PubMed ID: 23769654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and pharmacological evaluation of 4-[2-alkylthio-5(4)-(4-substitutedphenyl)imidazole-4(5)yl]benzenesulfonamides as selective COX-2 inhibitors.
    Salimi M; Ghahremani MH; Naderi N; Amini M; Salimi E; Amanlou M; Abdi K; Salehi R; Shafiee A
    Acta Pharmacol Sin; 2007 Aug; 28(8):1254-60. PubMed ID: 17640491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of 1,5-diaryl-1,2,4-triazole derivatives as selective cyclooxygenase-2 inhibitors.
    Jiang B; Zeng Y; Li MJ; Xu JY; Zhang YN; Wang QJ; Sun NY; Lu T; Wu XM
    Arch Pharm (Weinheim); 2010 Sep; 343(9):500-8. PubMed ID: 20842641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation.
    Singh SK; Vobbalareddy S; Kalleda SR; Rajjak SA; Casturi SR; Datla SR; Mamidi RN; Mullangi R; Bhamidipati R; Ramanujam R; Akella V; Yeleswarapu KR
    Org Biomol Chem; 2004 Sep; 2(17):2442-50. PubMed ID: 15326524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.
    Feng Z; Chu F; Guo Z; Sun P
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2270-2. PubMed ID: 19286379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.
    Almansa C; Alfón J; de Arriba AF; Cavalcanti FL; Escamilla I; Gómez LA; Miralles A; Soliva R; Bartrolí J; Carceller E; Merlos M; García-Rafanell J
    J Med Chem; 2003 Jul; 46(16):3463-75. PubMed ID: 12877584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrooxymethyl-substituted analogues of celecoxib: synthesis and pharmacological characterization.
    Boschi D; Lazzarato L; Rolando B; Filieri A; Cena C; Di Stilo A; Fruttero R; Gasco A
    Chem Biodivers; 2009 Mar; 6(3):369-79. PubMed ID: 19319873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.